triazoles has been researched along with Infections, Pseudomonas in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, K; Li, S; Lin, F; Wang, H; Zhang, Y | 1 |
| Albano, RM; Carvalho, S; da Conceição Costa, J; de Carvalho, L; de Oliveira Lima Santos, SA; Mallet de Lima, CD; Plotkowski, MC; Saliba, AM; Teixeira, MM | 1 |
| Moreau-Marquis, S; O'Toole, GA; Stanton, BA | 1 |
| Beral, L; Desbois, N; Donnio, A; Guyomarch, J; Merle, H; Olive, C; Theodose, R; van Nuoï, DN | 1 |
| Egawa, H; Fujita, M; Kataoka, M; Matsumoto, J; Miyamoto, T; Nakano, J | 1 |
| Kim, KH; Park, KW; Yim, CB | 1 |
6 other study(ies) available for triazoles and Infections, Pseudomonas
| Article | Year |
|---|---|
Inhibitory effects of novel 1,4-disubstituted 1,2,3-triazole compounds on quorum-sensing of P. aeruginosa PAO1.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Drug Resistance, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Triazoles; Virulence | 2021 |
Central role of PAFR signalling in ExoU-induced NF-κB activation.
Topics: Animals; Azepines; Bacterial Proteins; Bacterial Toxins; Cell Line; Enzyme Activation; Female; Gene Expression Regulation; Humans; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Promoter Regions, Genetic; Protein Binding; Pseudomonas aeruginosa; Pseudomonas Infections; Receptors, G-Protein-Coupled; Signal Transduction; Transcription Factor RelA; Triazoles | 2014 |
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.
Topics: Anti-Bacterial Agents; Benzoates; Biofilms; Cells, Cultured; Conalbumin; Cystic Fibrosis; Deferasirox; Deferoxamine; Epithelial Cells; Humans; Iron Chelating Agents; Pseudomonas Infections; Tobramycin; Triazoles; United States; United States Food and Drug Administration | 2009 |
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
Topics: Abscess; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Antifungal Agents; Benzamidines; Biguanides; Blindness; Contact Lenses; Corneal Opacity; Corneal Surgery, Laser; Female; Gentamicins; Humans; Keratitis; Middle Aged; Pseudomonas Infections; Pyrimidines; Retrospective Studies; Risk Factors; Serratia Infections; Staphylococcal Infections; Ticarcillin; Triazoles; Vancomycin; Voriconazole; Young Adult | 2010 |
Imidazo- and triazoloquinolones as antibacterial agents. Synthesis and structure-activity relationships.
Topics: Animals; Anti-Infective Agents; Bacteria; Gram-Negative Bacteria; Gram-Positive Bacteria; Imidazoles; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas Infections; Quinolones; Structure-Activity Relationship; Triazoles | 1995 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |